Today's story
IHH Unit Appeals Tokyo Court Dismissal of $1.1B Daiichi Sankyo Claim
IHH unit Northern TK Venture appealed a Tokyo court's Sept. 10, 2026 dismissal of its up-to-$1.1 billion damages claim against Daiichi Sankyo over Fortis delays.
Business · 7 sources · Sep 24, 2026Read itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About Daiichi Sankyo
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Everything about Daiichi Sankyo →- Country
- Japan
- Headquarters
- Chūō
- Inception
- 2005
- Website
- https://www.daiichisankyo.co.jp/